Anthera announces initiation of SOLUTION clinical study of oral Sollpura(R) (liprotamase)
Anthera announced initiation of the SOLUTION (Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in People With Cystic Fibrosis) Phase 3 clinical study evaluating efficacy and safety of Sollpura® (liprotamase), a microbial derived, biotech pancreatic enzyme replacement therapy. October 02, 2015